Biophar Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 3.50 M
- Paid Up Capital ₹ 3.45 M
- Company Age 14 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.58 Cr
- Revenue Growth 21.15%
- Profit Growth 19.16%
- Ebitda -54.23%
- Net Worth 440.15%
- Total Assets 29.93%
About Biophar Lifesciences
Biophar Lifesciences Private Limited (BLPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 16 July 2010 and has a history of 14 years and six months. Its registered office is in Chandigarh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.50 M and a paid-up capital of Rs 3.45 M.
The company currently has active open charges totaling ₹6.58 Cr.
Gulshan Rawat and Sunita serve as directors at the Company.
Company Details
-
Location
Chandigarh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24132CH2010PTC032343
-
Company No.
032343
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
16 Jul 2010
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
What products or services does Biophar Lifesciences Private Limited offer?
Biophar Lifesciences Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Gastrointestinal Drugs, Respiratory System Drugs, Anti Asthma Drug, Anti Infective Drugs & Medicines, Antibacterial Drugs, Cardiovascular Drugs & Medication, Diabetes Medicine, Malaria Medicine, Industrial Chemicals & Supplies.
Who are the key members and board of directors at Biophar Lifesciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gulshan Rawat
|
Director | 16-Jul-2010 | Current |
|
Sunita
|
Director | 21-Jan-2023 | Current |
Financial Performance of Biophar Lifesciences.
Biophar Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 21.15% increase. The company also saw a substantial improvement in profitability, with a 19.16% increase in profit. The company's net worth Soared by an impressive increase of 440.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biophar Lifesciences?
Unlock access to Biophar Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Rechelist Pharma Private LimitedGulshan Rawat is a mutual person
Charges (Loans)
₹65.83 M
₹0
Charges Breakdown by Lending Institutions
- Others : 3.50 Cr
- Canara Bank : 2.00 Cr
- Standard Chartered Bank : 0.75 Cr
- State Bank Of India : 0.25 Cr
- Icici Bank Limited : 0.08 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Dec 2023 | Canara Bank | ₹2.00 Cr | Open |
| 27 Apr 2023 | Others | ₹8.07 M | Open |
| 28 Nov 2022 | Others | ₹2.20 Cr | Open |
| 27 Oct 2020 | Standard Chartered Bank | ₹7.50 M | Open |
| 26 Aug 2020 | Others | ₹5.00 M | Open |
How Many Employees Work at Biophar Lifesciences?
Biophar Lifesciences has a workforce of 4 employees as of Oct 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biophar Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biophar Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
